Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Rangger, C; Helbok, A; von Guggenberg, E; Sosabowski, J; Radolf, T; Prassl, R; Andreae, F; Thurner, GC; Haubner, R; Decristoforo, C.
Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
Int J Nanomedicine. 2012; 7(4):5889-5900 Doi: 10.2147/IJN.S36847 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-authors Med Uni Graz
Prassl Ruth
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Purpose: Liposomes have been proposed to be a means of selectively targeting cancer sites for diagnostic and therapeutic applications. The focus of this work was the evaluation of radiolabeled PEGylated liposomes derivatized with varying amounts of a cyclic arginyl-glycyl-aspartic acid (RGD) peptide. RGD peptides are known to bind to alpha(v)beta(3) integrin receptors overexpressed during tumor-induced angiogenesis. Methods: Several liposomal nanoparticles carrying the RGD peptide targeting sequence (RLPs) were synthesized using a combination of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, cholesterol, diethylenetriaminepentaacetic acid-derivatized lipids for radiolabeling, a polyethylene glycol (PEG) building block, and a lipid-based RGD building block. Relative amounts of RGD and PEG building blocks were varied. In vitro binding affinities were determined using isolated alpha(v)beta(3) integrin receptors incubated with different concentrations of RLPs in competition with iodine-125-labeled cyclo-(-RGDyV-). Binding of the indium-111-labeled RLPs was also evaluated. Biodistribution and micro single photon emission computed tomography/computed tomography imaging studies were performed in nude mice using different tumor xenograft models. Results: RLPs were labeled with indium-111 with high radiochemical yields. In vitro binding studies of RLPs with different RGD/PEG loading revealed good binding to isolated receptors, which was dependent on the extent of RGD and PEG loading. Binding increased with higher RGD loading, whereas reduced binding was found with higher PEG loading. Biodistribution showed increased circulating time for PEGylated RLPs, but no dependence on RGD loading. Both biodistribution and micro single photon emission computed tomography/computed tomography imaging studies revealed low, nonspecific tumor uptake values. Conclusion: In this study, RLPs for targeting angiogenesis were described. Even though good binding to alpha(v)beta(3) integrin receptors was found in vitro, the balance between PEGylation and RGD loading clearly requires optimization to achieve targeting in vivo. These data form the basis for future development and provide a platform for the investigation of multimodal approaches.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Antineoplastic Agents - administration & dosage
Crystallization - methods
Female -
Indium - diagnostic use
Isotope Labeling -
Liposomes - chemistry
Materials Testing -
Mice -
Mice, Inbred C57BL -
Mice, Nude -
Nanocapsules - chemistry
Neoplasms, Experimental - drug therapy
Oligopeptides - administration & dosage
Organ Specificity -
Polyethylene Glycols - chemistry
Radiopharmaceuticals - diagnostic use
Tissue Distribution -

Find related publications in this database (Keywords)
liposomes
RGD peptides
alpha(v)beta(3) integrin receptors
angiogenesis
tumor targeting
© Med Uni GrazImprint